Re: Surrogate End Points for All-Cause Mortality in Men with Localized Unfavorable-Risk Prostate Cancer Treated with Radiation Therapy vs Radiation Therapy plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial

J Urol. 2018 Jan;199(1):28. doi: 10.1016/j.juro.2017.10.008. Epub 2017 Oct 6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biomarkers*
  • Humans
  • Male
  • Prostatic Neoplasms*

Substances

  • Biomarkers